These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 19417148

  • 1. Darinaparsin induces a unique cellular response and is active in an arsenic trioxide-resistant myeloma cell line.
    Matulis SM, Morales AA, Yehiayan L, Croutch C, Gutman D, Cai Y, Lee KP, Boise LH.
    Mol Cancer Ther; 2009 May; 8(5):1197-206. PubMed ID: 19417148
    [Abstract] [Full Text] [Related]

  • 2. A novel arsenical has antitumor activity toward As2O3-resistant and MRP1/ABCC1-overexpressing cell lines.
    Diaz Z, Mann KK, Marcoux S, Kourelis M, Colombo M, Komarnitsky PB, Miller WH.
    Leukemia; 2008 Oct; 22(10):1853-63. PubMed ID: 18633430
    [Abstract] [Full Text] [Related]

  • 3. BH3-only proteins Noxa, Bmf, and Bim are necessary for arsenic trioxide-induced cell death in myeloma.
    Morales AA, Gutman D, Lee KP, Boise LH.
    Blood; 2008 May 15; 111(10):5152-62. PubMed ID: 18354037
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Alterations in glutathione levels and apoptotic regulators are associated with acquisition of arsenic trioxide resistance in multiple myeloma.
    Matulis SM, Morales AA, Yehiayan L, Lee KP, Cai Y, Boise LH.
    PLoS One; 2012 May 15; 7(12):e52662. PubMed ID: 23285138
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Arsenic trioxide combined with buthionine sulfoximine enhances apoptosis in multidrug-resistant human leukemia K562/ADM cells in vitro].
    Wang T, Ma LM, Zhang HP, Wang HW, Yang LH, Qiao ZH.
    Zhonghua Zhong Liu Za Zhi; 2008 Mar 15; 30(3):188-91. PubMed ID: 18756933
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Arsenic trioxide-enhanced, matrine-induced apoptosis in multiple myeloma cell lines.
    Yu Q, Chen B, Zhang X, Qian W, Ye B, Zhou Y.
    Planta Med; 2013 Jun 15; 79(9):775-81. PubMed ID: 23700110
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Mechanism of arsenic trioxide-induced cytotoxicity on multiple myeloma cells].
    Chen YB, Hou J, Fu WJ, Ding SQ, Wang DX, Yuan ZG, Kong XT.
    Ai Zheng; 2003 Dec 15; 22(12):1276-9. PubMed ID: 14693051
    [Abstract] [Full Text] [Related]

  • 13. Darinaparsin: solid tumor hypoxic cytotoxin and radiosensitizer.
    Tian J, Zhao H, Nolley R, Reese SW, Young SR, Li X, Peehl DM, Knox SJ.
    Clin Cancer Res; 2012 Jun 15; 18(12):3366-76. PubMed ID: 22535156
    [Abstract] [Full Text] [Related]

  • 14. Induction of apoptosis in arsenic trioxide-treated lung cancer A549 cells by buthionine sulfoximine.
    Han YH, Kim SZ, Kim SH, Park WH.
    Mol Cells; 2008 Aug 31; 26(2):158-64. PubMed ID: 18596414
    [Abstract] [Full Text] [Related]

  • 15. Darinaparsin: a novel organic arsenical with promising anticancer activity.
    Mann KK, Wallner B, Lossos IS, Miller WH.
    Expert Opin Investig Drugs; 2009 Nov 31; 18(11):1727-34. PubMed ID: 19780704
    [Abstract] [Full Text] [Related]

  • 16. Arsenic trioxide cytotoxicity in steroid and chemotherapy-resistant myeloma cell lines: enhancement of apoptosis by manipulation of cellular redox state.
    Gartenhaus RB, Prachand SN, Paniaqua M, Li Y, Gordon LI.
    Clin Cancer Res; 2002 Feb 31; 8(2):566-72. PubMed ID: 11839678
    [Abstract] [Full Text] [Related]

  • 17. JNK activation is a mediator of arsenic trioxide-induced apoptosis in acute promyelocytic leukemia cells.
    Davison K, Mann KK, Waxman S, Miller WH.
    Blood; 2004 May 01; 103(9):3496-502. PubMed ID: 14701702
    [Abstract] [Full Text] [Related]

  • 18. Changes in gene expression profiles of multiple myeloma cells induced by arsenic trioxide (ATO): possible mechanisms to explain ATO resistance in vivo.
    Zhou P, Kalakonda N, Comenzo RL.
    Br J Haematol; 2005 Mar 01; 128(5):636-44. PubMed ID: 15725085
    [Abstract] [Full Text] [Related]

  • 19. Elimination of the differential chemoresistance between the murine B-cell lymphoma LY-ar and LY-as cell lines after arsenic (As2O3) exposure via the overexpression of gsto1 (p28).
    Giri U, Terry NH, Kala SV, Lieberman MW, Story MD.
    Cancer Chemother Pharmacol; 2005 Jun 01; 55(6):511-21. PubMed ID: 15761769
    [Abstract] [Full Text] [Related]

  • 20. Sulforaphane synergistically enhances the cytotoxicity of arsenic trioxide in multiple myeloma cells via stress-mediated pathways.
    Doudican NA, Wen SY, Mazumder A, Orlow SJ.
    Oncol Rep; 2012 Nov 01; 28(5):1851-8. PubMed ID: 22922937
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.